Envestnet Asset Management
SGNT

Envestnet Asset Management’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Envestnet Asset Management’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-3,771
Closed -$56K – 3165
2016
Q2 		$56K Sell
3,771
-459
-11% -$5.9K ﹤0.01% 2686
2016
Q1 		$51K Sell
4,230
-157
-4% -$2.2K ﹤0.01% 2717
2015
Q4 		$70K Buy
4,387
+873
+25% +$13.7K ﹤0.01% 2532
2015
Q3 		$54K Buy
+3,514
New +$76K ﹤0.01% 2625

Envestnet Asset Management's SGNT Position: Q3 2016 in Review

Envestnet Asset Management sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 3,771 shares — an estimated $56K sold.

Envestnet Asset Management first reported a position in SGNT in Q3 2015 and held it in 4 quarters. The position peaked at $70K in Q4 2015. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Envestnet Asset Management reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Envestnet Asset Management sold 3,771 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $56K.
  • Envestnet Asset Management first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2015 and held it in 4 quarters.
  • Envestnet Asset Management's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $70K in Q4 2015.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Envestnet Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.